Latest News
SK Biopharmaceuticals submits cenobamate supplemental New Drug Application to US FDA
5 November 2026 - SK Biopharmaceuticals Co Ltd, a South Korea-based pharmaceutical company, announced on Wednesday that it has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) seeking approval of cenob...
Circular Genomics and PharmatrophiX collaborate on advancing circRNA biomarkers in neurodegenerative drug development
5 November 2026 - Circular Genomics Inc, a precision neurology company developing circular RNA (circRNA)-based biomarkers, and PharmatrophiX Inc, a clinical-stage biopharmaceutical company developing disease-modifying therapies for neurodegenerative ...
Viatris to pay quarterly dividend of USD0.12 per share
5 November 2026 - Global healthcare company Viatris Inc (Nasdaq:VTRS) announced on Wednesday that on its board of directors has declared a quarterly dividend of USD0.12 per share for each issued and outstanding share of the company's common stoc...
Minghui Pharmaceutical licenses IGF-1R antibody to ASKA Pharmaceutical in Japan
5 November 2026 - Chinese pharmaceutical company Minghui Pharmaceutical and ASKA Pharmaceutical Co Ltd, a subsidiary of Japan's ASKA Pharmaceutical Holdings Co Ltd (TSE:4886), announced on Wednesday that they have entered into an exclusive licen...
WuXi Biologics receives two awards at 2026 HERA
5 November 2026 - WuXi Biologics (HKG:2269), a China-based global Contract Research, Development and Manufacturing Organisation (CRDMO), announced on Tuesday that it received two Grand Awards at the ninth Hong Kong ESG Reporting Awards (HERA), winnin...